Baxalta wins FDA approval with a treatment for a rare bleeding disease

Damian Garde

picked up FDA for a drug that treats von Willebrand , a inherited disorder that results from a missing protein.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS